Related by context. Frequent words. (Click for all words.) 74 Initiates Phase II 72 Presents Positive 71 Completes Enrollment 71 www.vivus.com 70 Inc Therapeutic Competitors 70 please visit http:/www.supergen.com 70 Welcomes Analyst Initiation 69 www.combinatorx.com 69 Receives Orphan Drug Designation 69 Advancing Drugs 69 Files Shelf Registration Statement 69 Marcus Gronholm BP 68 http:/www.nabi.com 68 VEGFR2 inhibitor 68 Inc. Nasdaq IMGN 68 Nasdaq ENMD 68 www.allos.com 68 www.incyte.com 68 Enrolls First 68 www.vical.com 68 R sorafenib tablets 68 Commences Phase 68 Antigen Express website 68 www.syntapharma.com 67 www.schering plough.com 67 * Azixa 67 Inc. NASDAQ QLTI 67 YOUR LOCAL ANIMAL SHELTER 67 By Thomas Gryta 67 Earnings Postmortem 67 Post Earnings Checkup 67 www.cardiome.com 67 sanofi aventis GlaxoSmithKline 67 By Neil Osterweil 67 developing Zerenex TM 67 PINNACLEDIGEST.COM S PAST PERFORMANCE 67 www.polymedix.com 67 Meets Primary Endpoint 67 Initiates Phase 67 Inc. Nasdaq GTXI 67 www.questcor.com 66 www.spectrumpharm.com 66 www.twitter.com otcadvisors 66 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 66 www.gpc biotech.com 66 Vytorin combines 66 interferon gamma 1b 66 symbol SIRF 66 www.BMRN.com 66 Q1 Loss Narrows 66 Joseph Levi Esq 66 Rolls Royce Scion 66 Q2 Loss Narrows 66 refractory chronic lymphocytic 66 Jumps Higher 66 MKC# 66 regarding Palatin 66 Q3 Loss Narrows 66 By RICK KRETZSCHMAR 66 Takeda Kyowa Hakko Kirin 66 www.holliseden.com 66 www.delcath.com 66 inflammatory autoimmune diseases 66 http:/www.curagen.com 66 Q3 Loss Widens 66 By XiaoBing #-#-# 66 www.dyax.com 66 Nasdaq OSIP 66 www.lexpharma.com 65 Entereg R 65 www.celgene.com 65 THE MORTGAGOR THE MORTGAGOR 65 http:/www.schering-plough.com 65 SMARTREND WATCHING FOR 65 Inc. Nasdaq TRMS 65 irresponsible nuisances 65 www.caliperLS.com 65 Note SHIPPING CHARGES 65 visit www.PAREXEL.com 65 http:/www.optimerpharma.com 65 Inc. NASDAQ TRGT 65 www.hanabiosciences.com 65 By HARVEY SIMPSON 65 2 methoxyestradiol 65 www.exelixis.com 65 WHICH ARE NOT PURELY 65 Ariba logo AribaLIVE 65 #mins #.#secs M 65 Calls Purchased 65 BioSante licensees 65 Q4 Loss Widens 65 Q2 Loss Widens 65 Attracting Bullish Investors 65 ENTIRETY BECAUSE THEY CONTAIN 65 Nasdaq ADLR 65 By Katy Burne 65 BY RYAN ERNST 65 Q4 Loss Narrows 65 phenylketonuria PKU developed 65 Company Nasdaq PRGO 65 Bearish Pressure Building